Vaxcyte Inc
NASDAQ:PCVX
Cash Flow Statement
Cash Flow Statement
Vaxcyte Inc
| Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||
| Net Income |
(64)
|
(73)
|
(94)
|
(89)
|
(83)
|
(87)
|
(92)
|
(100)
|
(118)
|
(143)
|
(174)
|
(223)
|
(245)
|
(265)
|
(300)
|
(402)
|
(437)
|
(497)
|
(508)
|
(464)
|
(510)
|
(547)
|
(657)
|
|
| Depreciation & Amortization |
1
|
1
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
12
|
7
|
9
|
10
|
5
|
|
| Stock-Based Compensation |
1
|
2
|
4
|
5
|
7
|
8
|
10
|
11
|
13
|
16
|
20
|
24
|
29
|
36
|
42
|
49
|
57
|
66
|
74
|
85
|
98
|
113
|
127
|
|
| Other Non-Cash Items |
(2)
|
1
|
3
|
6
|
8
|
9
|
11
|
14
|
18
|
22
|
27
|
38
|
37
|
31
|
23
|
21
|
24
|
35
|
40
|
59
|
71
|
67
|
96
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
13
|
24
|
30
|
35
|
28
|
10
|
(2)
|
(37)
|
(38)
|
(28)
|
(11)
|
13
|
15
|
17
|
40
|
81
|
1
|
(10)
|
(14)
|
(55)
|
(30)
|
11
|
14
|
|
| Cash from Operating Activities |
(51)
N/A
|
(47)
+8%
|
(60)
-28%
|
(47)
+22%
|
(46)
+1%
|
(66)
-42%
|
(81)
-23%
|
(121)
-50%
|
(136)
-12%
|
(146)
-8%
|
(156)
-7%
|
(171)
-9%
|
(191)
-12%
|
(214)
-12%
|
(233)
-9%
|
(297)
-27%
|
(408)
-38%
|
(467)
-15%
|
(470)
-1%
|
(453)
+4%
|
(460)
-2%
|
(459)
+0%
|
(542)
-18%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||
| Capital Expenditures |
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(4)
|
(6)
|
(7)
|
(8)
|
(7)
|
(6)
|
(6)
|
(9)
|
(5)
|
(12)
|
(68)
|
(74)
|
(115)
|
(146)
|
(119)
|
(134)
|
(105)
|
(79)
|
|
| Other Items |
0
|
0
|
0
|
0
|
(172)
|
(190)
|
(207)
|
(206)
|
19
|
64
|
117
|
80
|
(415)
|
(777)
|
(783)
|
(705)
|
(702)
|
(407)
|
(1 316)
|
(1 887)
|
(1 297)
|
(1 169)
|
(156)
|
|
| Cash from Investing Activities |
(2)
N/A
|
(1)
+7%
|
(1)
+1%
|
(1)
+21%
|
(174)
-15 589%
|
(195)
-12%
|
(213)
-10%
|
(212)
+0%
|
11
N/A
|
57
+434%
|
111
+93%
|
75
-33%
|
(423)
N/A
|
(783)
-85%
|
(795)
-2%
|
(773)
+3%
|
(776)
0%
|
(523)
+33%
|
(1 462)
-180%
|
(2 006)
-37%
|
(1 431)
+29%
|
(1 274)
+11%
|
(235)
+82%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||
| Net Issuance of Common Stock |
153
|
421
|
421
|
378
|
269
|
2
|
10
|
18
|
21
|
70
|
107
|
862
|
901
|
853
|
860
|
644
|
606
|
715
|
765
|
2 463
|
2 464
|
2 356
|
2 255
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(1)
|
(4)
|
(4)
|
(3)
|
(3)
|
(0)
|
0
|
0
|
108
|
108
|
107
|
(1)
|
(109)
|
436
|
434
|
(4)
|
810
|
265
|
1 681
|
(14)
|
(833)
|
(833)
|
(2 251)
|
|
| Cash from Financing Activities |
151
N/A
|
416
+175%
|
416
+0%
|
375
-10%
|
266
-29%
|
2
-99%
|
10
+372%
|
18
+86%
|
128
+621%
|
177
+38%
|
214
+21%
|
862
+303%
|
792
-8%
|
1 289
+63%
|
1 294
+0%
|
640
-51%
|
1 416
+121%
|
980
-31%
|
2 446
+150%
|
2 449
+0%
|
1 631
-33%
|
1 523
-7%
|
5
-100%
|
|
| Change in Cash | ||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
0
|
0
|
1
|
2
|
(7)
|
(1)
|
(2)
|
(9)
|
0
|
(4)
|
(2)
|
4
|
|
| Net Change in Cash |
99
N/A
|
368
+272%
|
355
-4%
|
327
-8%
|
45
-86%
|
(258)
N/A
|
(284)
-10%
|
(316)
-11%
|
3
N/A
|
87
+3 003%
|
166
+91%
|
766
+360%
|
179
-77%
|
293
+64%
|
267
-9%
|
(437)
N/A
|
231
N/A
|
(12)
N/A
|
505
N/A
|
(9)
N/A
|
(264)
-2 726%
|
(212)
+20%
|
(769)
-262%
|
|
| Free Cash Flow | ||||||||||||||||||||||||
| Free Cash Flow |
(53)
N/A
|
(48)
+8%
|
(61)
-27%
|
(48)
+22%
|
(48)
-1%
|
(70)
-45%
|
(87)
-24%
|
(128)
-47%
|
(144)
-13%
|
(153)
-6%
|
(163)
-6%
|
(176)
-9%
|
(199)
-13%
|
(220)
-10%
|
(245)
-12%
|
(365)
-49%
|
(482)
-32%
|
(583)
-21%
|
(616)
-6%
|
(572)
+7%
|
(594)
-4%
|
(564)
+5%
|
(621)
-10%
|
|